Anda di halaman 1dari 6

DAFTAR PUSTAKA

Albert, H., Bwanga, F., Mukkada, S. 2010. Rapid Screening of TB MDR Using
Molecular Line Probe Assay in Feasible in Uganda. BMC Infectious Diseases.
10(41). 1471- 9

Amin, Z., Bahar, A. 2014. Tuberkulosis Paru. Dalam: Buku Ajar Ilmu Penyakit
Dalam. Jilid I. Edisi VI. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit
Dalam Fakultas Kedokteran Universitas Indonesia. Hal: 864-8.

Bacahoglu, F., Basoghu, OK., Cog, G., Saymer, A. 2011. Pulmonary tuberculosis in
patients with Diabetes Mellitus. Respirology. 68:595-600.

Blakemore, R., Story, E., Helb, D., Kop, J. 2010. Evaluation of Analytical
Performance of The Xpert MTB/RIF Assay. 48(7): 2495-501.

Burhan, E. 2010. Peran ISTC dalam Pencegahan MDR. Jurnal Tuberkulosis


Indonesia. 7:12-5.

Boehme, CC. 2009. Study Protocol-Xpert MTB/RIF Demonstration-feasibility,


Impact, and Cost-efficiency of Decentralizing Molecular Testing for
Detection of Tuberculosis and Rifampisin Resistance Using Xpert MTB/RIF.
1495-505

Boehme, CC., Nabeta P., Hilleman D., Nicol PM., Shenai S., Krapp F., at al. 2010.
Rapid Molecular Detection of Tuberculosis and Rifampisin Resistance. The
New England Journal of Medicine. 363(11):1005-15.

Boulware, LR. 2013. Utility of The Xpert MTB/RIF Assay for Diagnosis of
Tuberculosis Meningitis. PLoS Med. 10(10). 11-8

Calligaro, G., Moodley, L., Symons, G., Dheda, K. 2014. The Medical and Surgical
Treatment of Drug Resistant Tuberculosis. Journal Thoracal Diseases. 6(3).
186-95.

Chiang CY, Centis R, Migliori GB. 2010. Drug Resistant Tuberculosis: past, present,
future. Respirology. 15(3):413-32.

Departemen Kesehatan Republik Indonesia, 2009. Pedoman Nasional


Penanggulangan Tuberkulosis. Jakarta: Depkes RI. 80

Departemen Kesehatan Republik Indonesia. 2013. Pedoman Manajemen Terpadu


Pengendalian Tuberkulosis Resisten Obat. Jakarta : Depkes RI. 15-26

77

Fakultas Kedokteran Universitas Andalas


Dwiastuti, I. 2012. Analisis Prilaku Pada Kejadian TB Paru Resisten di Kota
Makassar [Skripsi]. Fakultas Kesehatan Masyarakat Universitas Hasanuddin
Makssar. 42-3

Evans, CA. 2011. GeneXpert- A Game Changer For Tuberculosis Control?. PLoS
Med. 8(7). 56-69

Falzon, D., Mirzayev, F., Wares, F., Baena G., Zignol M., Linh N., et al. 2014.
Multidrug- resistant tuberculosis around the world: What Progress Has Been
Made ?. European Respiratory journal. 150-60

Hakeem, A., Hussain, MS., Imran, MI. 2013. GeneXpert MTB/RIF- A Novel
Diagnostic Tool for Tuberculosis in Pulmonary Samples. 8: 1-3.

Hillemann, D., Weizenegger, M., Kubicat., Richter, E., Niemann, S. 2005. Use of the
Genotype TB MDR Assay for Rapid Detection of Rifampisin and Isoniazid
Resistance in Mycobacterium tuberculosis Complex Isolates. Journal of
Clinical Microbiology. 43(8): 3699-703.

Hirpa, S., Medhin, G., Girma, B., Melese, M., mekonen, A., Suarez, P., et al. 2013.
Determinants of multidrug-resistant tuberculosis in patients who underwent
first-line treatment in Addis Ababa: a case control study. BMC Public Health.
13: 782.

Kasper, DL., Braunwald, S., Hauser, D., Longo, L., Jameson., and Fauci. 2008.
“Tuberculosis,” in Harrison's Principle of Internal Medicine, pp., McGraw-
Hill, New York, NY, USA, 17th edition. 953–66

Kementerian Kesehatan Republik Indonesia. 2011. Rencana Aksi Nasional


Programmatic Management of Drug Resistance Tuberculosis. Direktorat
Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. 40-5

Kementerian Kesehatan Republik Indonesia. 2013. Pedoman Nasional Pelayanan


Kedokteran Tatalaksana Tuberkulosis. 30-6

Kementerian Kesehatan Republik Indonesia. 2014. Pedoman Nasional Pengendalian


Tuberkulosis. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan
Lingkungan. 51-60

Lawn SD, Nicol MP. 2011. Xpert MTB/RIF Assay: Development, Evaluation, and
Implementation of a New Rapid Molecular Diagnostic for Tuberculosis and
Rifampisin Resistance. Future Microbiology. 6(9):1067-82.

78

Fakultas Kedokteran Universitas Andalas


Lawn, SD., Wood R. 2011. Tuberculosis in Antiretroviral Treatment Services in
Resources Unlimited Setting ; Adressing the Challenges of Screening and
Diagnosis. Journal Infectious Disease. 204: 1159-67.

Li J, Xin J, Zhang L, Jiang L, Cao H, Li L. 2012. Rapid Detection of rpoB Mutations


in Rifampisin Resistant Mycobacterium tuberculosis from Sputum Samples by
Denaturing Gradient Gel Electrophoresis. Int J Med Sci. 9(2):148-56.
Makadia JS, Jain A, Patra SK, Sherwai BL, Khanna A. 2012. Emerging trend of
mutation profile of rpob gene in MDR tuberculosis, North India. Ind J Clin
Biochem. 27(4): 370-4.

Marlowe, EM., Novan, SM., Cumpio, J. 2011. Evalution of The Cepheid Xpert
MTB/RIF Assay for Direct Detection of Mycobacterium Tuberculosis
Complexin Respiratory Speciments, Journal Clinical Microbiology. 49(4).
1621.

Munir, S.M., Nawas, A., dan Soetoyo, D. 2010. Pengamatan Pasien Tuberkulosis
Paru dengan Multidrug Resistant (TB-MDR) di Poliklinik Paru RSUP
Persahabatan. Jurnal Respirologi Indonesia. 30(2): 92-9.

Nawas, A. 2010. Penatalaksanaan TB MDR dan Strategi DOTS Plus. Jurnal


Tuberkulosis Indonesia. 7: 1-6.

Nikmawati, Windarwati, dan Hardjoeno. 2005. Resistensi Mycobacterium


tuberculosis terhadap Obat Anti Tuberkulosis. Indonesian Journal of clinical
Pathology and Medical Laboratory. 12(2): 58-61.

Noviana H, Nurachman Z, Ramdani M, Noe A. 2007. Multiplex PCR for rapid


detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis
Isolated from Bandung, Indonesia. Microbiology Indonesia. 1(3):114-8.
Nofizar, D., Nawas, A., dan Burhan, E. 2010. Identification of Risk Factor in
Multidrug Resistant Tuberculosis. Majalah Kedokteran Indonesia. 60(12):
538-54.

Pant, R., Pandey, KR., Joshi, M., Sharma, M., Pandey, T., Pandey, S. 2009. Risk
Factor Assesment of Multidrug Resistant Tuberculosis. 7(15): 89-92.

Perhimpunan Dokter Paru Indonesia. 2011. Pedoman Diagnosis dan Penatalaksanaan


Tuberkulosis di Indonesia. 43-5

Price, S.A., Wilson, L.M. 2012. Patofisiologi: Konsep Klinis Proses-Proses Penyakit.
Edisi 6. Jakarta: EGC. 852

79

Fakultas Kedokteran Universitas Andalas


Putri, AV., Yozi, I., Fauzia, D. 2015. Profil Pasien Tuberkulosis Multidrug
Resistance (TB MDR) di Poliklinik TB MDR RSUD Arifin Achmad Provinsi
Riau Periode April 2013-Juni 2014. JOM. 1(2). 1-8

Raizada, N., Sachdeva, KS., Chauhar, DS., et al. 2014. A Multi-site Validation in
India of the Line Probe Assay for the Rapid Diagnosis of Multi Drug-resistant
Tuberculosis Directly From Sputum Speciments. PLoS One. 9(2). 1-8

Ramirez, MV., Cowart, KC. Campbell, PJ., Morlock, GP., Sikes, D., Winchell, JM.,
et al. 2010. Rapid Detection of Multidrug Resistant Mycobacterium
tuberculosis by Use Realtime PCR and High Resolution Melt analysis. J Clin
Microbiology. 48(11): 4003-9.

Rufai, BS., Kumar, P., Singh, A., Prajapati, S., Balboni, V., Singh, S. 2014.
Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of
Rifampisin Resistance-Monoresistant Mycobacterium tuberculosis. JCM.
52(6): 1846-52

Sarwani, D., Nurlaela, S., Zahratul, I. 2012. Analisis Faktor Risiko Multidrug
Resistant Tuberculosis (TB MDR) (Studi Kasus di BP4 Purwokerto). Jurnal
Kesehatan Masyarakat. 8(1): 62-8.

Sihombing, H., Sembiring, H., Amir, Z., dan Sinaga, B. 2011. Pola Resistensi Primer
pada Penderita TB Paru Kategori I di RSUP H. Adam Malik Medan. Jurnal
Respirasi Indonesia. 32(2):138-45.

Sinaga, M.Y. 2013. Karakteristik penderita Multidrug Resistant Tuberculosis yang


mengikuti Programmatic Management of Drug Resistant Tuberculosis di
Rumah Sakit Umum Pusat H.Adam Malik Medan. Jurnal Respirasi Indonesia.
33(4): 221-8.

Soedarsono. 2010. Multidrugs-Resistant (MDR) TB. Dalam: Buku Ajar Ilmu


Penyakit Paru 2010. Surabaya: Departemen Ilmu Penyakit Paru Fakultas
Kedokteran Universitas Airlangga- RSUD Dr. Soetomo. Hal: 27-36.

Soepandi P.Z. 2010. Diagnosis dan Penatalaksanaan TB MDR. Jakarta: Depatemen


Pulmonologi dan Ilmu Kedokteran Respirasi FKUI- RSUP Persahabatan. 497-
501

Steingart, KR, Sohn, N., Shiller, L. 2013. Xpert MTB/RIF Assay for Pulmonary
Tuberculosis and Rifampisin Resitance in Adults (Review). 1: 1-35.

Syahrini, H. 2008. Tuberkulosis Paru Resistensi Ganda. USU e-Repository. Medan:


Fakultas Kedokteran USU. 10-2

80

Fakultas Kedokteran Universitas Andalas


Tirtana, BT. 2011. Faktor-faktor yang Mempengaruhi Keberhasilan Pengobatan pada
Pasien Tuberkulosis Paru dengan Resistensi Obat Tuberkulosis di Wilayah
Jawa Tengah [skripsi]. Semarang : Fakultas Kedokteran Universitas
Diponegoro. 1-19

Trebucq, A, Enarson, DA., Chiang, CY. 2011. Xpert MTB/RIF for National
Tuberculosis Programmes in Low Incomes Countries: When, Where, and
How?. Int J Tuberculosis Lung Diseases.15(12): 1567-71.

Van Rie, A., Page-ship, L., Scott, L., Sanne, I., Steven, W. 2010. Xpert MTB/RIF for
Point Care Diagnosis of TB in High HIV Burden, Resources Limited
Countries: Hype or Hope?. Expert Mol diagn. 10(7): 937-46.

TB MDR. Manajemen Terpadu Pengendalian TB Resisten Obat (MTPTRO)


http://www.tbindonesia.or.id/tb-mdr/ diakses tanggal 25 Maret 2015

TB-MDR. http://indonesia.etbmanager.org/blog/?page_id=221 diakses tanggal 30 Mei


2015

World Health Organization . Guidelines for the Programmatic Management of Drug-


Resistant Tuberculosis: Emergency Update 2013. Geneva: WHO Press 2013.

World Health Organization. Drug Resistant TB: Surveillance and Response. Geneva:
WHO Press 2014.

World Health Organization. Global Tuberculosis Report 2015. Geneva: WHO Press
2015.

World Health Organization. Molecular Line Probe Assay for Rapid Screening of
Patients at Risk of Multidrug Resistant Tuberculosis (TB MDR). Geneva:
WHO; 2008.

World Health Organization. Rapid Implementation of the Xpert MTB/RIF Diagnostic


Test. Geneva: WHO; 2011.

World Health Organization. Tuberculosis Diagnostics Xpert MTB/RIF Test. Geneva:


WHO 2013

World Health Organization. The Global Plan to Stop TB 2011-2015. Geneva: WHO
2011.

Yadav, RN., Singh, BK., Sharma, SK. Comparative Evaluation of Genotype


MTBDRplus Line Probe Assay With Solid Culture Method In Early
Diagnosis of Multidrug Resistant Tuberculosisat a Tertiary Care Center in
India. PLoS One. 1-6
81

Fakultas Kedokteran Universitas Andalas


Yuan, X., Zhang, T., Kawakami, K., et al. 2013. Genotyping and Clinical
Characteristics of Multidrug and Extensively Drug Resistant Tuberculosis in
Tertiary Care Tuberculosis Hospital in China. BMC Infectious Diseases.
13(385). 525-30

82

Fakultas Kedokteran Universitas Andalas